Ogivri 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
7680674670018
CH-67467
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Associated product:
OGIVRI 150 mg subst sèche flac perf 1 pce
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
trastuzumabum
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
sorbitolum
|
115.2 MG | Substance | HBESI |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
0.07 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 513.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2020
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 67467
- Drug name
- Ogivri 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L01FD01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 02/04/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- OGIVRI 150 mg subst sèche flac perf 1 pce
- Description (DE)
- OGIVRI 150 mg Trockensub 1 Durchstf 1 Stk
- Market launch
- 02/04/2020
- Narcotic (BTM)
- No